Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug

HOUSTON – February 5, 2018 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced that the US […]

Future Farm to Expand Ownership in Puerto Rico Dispensaries

Company to increase interest in Puerto Rican subsidiary as product demand soars on the island   Vancouver, British Columbia, Feb. 05, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that it has reached an agreement with its Puerto Rico […]

The Bell-Shaped Curve of Cannabis – CBD Infused Product Users

Palm Beach, FL – (February 5, 2019) – $5.7 BILLION by next year and $22 BILLION by 2022!  That is what the market research firm the Brightfield Group projects, in an article published by the BBC. If anyone has ever wondered who, exactly, is actually buying all of these CBD infused products, here’s the answer. […]

Billion Dollar U.S. Medical Device Sector Should Continue To Thrive

Palm Beach, FL – (February 5, 2019) – Most know the phrase, “The Business of America is Business”, although that is not exactly what Calvin Coolidge actually said, it has aptly described the role of the United States in world commerce since World War II.  What Coolidge actually said was: “the chief business of the […]


Escondido, CA — (February 5, 2019) – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary hempSMART™, attended special promotional events for its CBD infused product line during Super Bowl LIII this past weekend. The events included Ray Lewis’s […]

BioSig Appoints John Kowalski to Lead Commercialization of PURE EP

Electrophysiology Industry Veteran to Lead Sales Strategy For the Company’s Novel Cardiac Signal Acquisition and Processing Technology   Santa Monica, CA, February 4, 2019 — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that […]

Franchise Holdings International 2019 revenues trending towards 1100% year over year growth

Profitability forecasted within 2019   TORONTO, Ontario, February 5th, 2019 – Franchise Holdings International (OTCQB: FNHI), Worksport Ltd.’s parent company, said it was on track to achieve revenues representing at least a 1100 per cent increase year over year, when compared with 2018. Worksport, an innovative manufacturer of high quality, functional, and aggressively priced tonneau/truck […]

Innovative AI-Lithium Play – Rapid Extraction Key to Unlocking US Lithium Resources

New York NY – February 5, 2019 – Conflicting reports regarding Warren Buffett’s Berkshire Hathaway’s recent alleged interest in new US-based lithium extraction technologies has shone a spotlight on a rising need for innovation. Beyond Buffett’s group, there has already been a push from the lithium sector to innovate, from companies including Standard Lithium Ltd. […]